throbber
HANDBOOK OF
`CORONARY STENTS
`FOURTH EDITION
`
`Editors
`Patrick W Serruys • Benno J Rensing
`
`CRC Press
`Taylor & Francis Group
`
`Page 1
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`HANDBOOK OF CORONARY STENTS
`FOURTH EDITION
`Serruys .Reusing
`
`Page 2
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Second edition 1998
`Reprinted 1998
`Third edition 2000
`Reprinted 2000
`
`CRC Press
`Taylor & Francis Group
`6000 Broken Sound Parkway NW, Suite 300
`Boca Raton, FL 33487-2742
`
`First issued in paperback 2019
`
`© 2002 by Taylor & Francis Group, LLC
`CRC Press is an imprint of Taylor & Francis Group, an Informa business
`
`No claim to original U.S. Government works
`
`ISBN-13:978-1-84184-093-2 (hbk)
`ISBN-13:978-0-367-39665-7 (pbk)
`
`This book contains information obtained from authentic and highly regarded sources. Reasonable efforts
`have been made to publish reliable data and information, but the author and publisher cannot assume
`responsibility for the validity of all materials or the consequences of their use. The authors and publishers
`have attempted to trace the copyright holders of all material reproduced in this publication and apologize to
`copyright holders if permission to publish in this form has not been obtained. If any copyright material has
`not been acknowledged please write and let us know so we may rectify in any future reprint.
`
`Except as permitted under U.S. Copyright Law, no part of this book maybe reprinted, reproduced, transmit­
`ted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented,
`including photocopying, microfilming, and recording, or in any information storage or retrieval system,
`without written permission from the publishers.
`
`For permission to photocopy or use material electronically from this work, please access www.copyright.
`com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC), 222 Rosewood
`Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and
`registration for a variety of users. For organizations that have been granted a photocopy license by the CCC,
`a separate system of payment has been arranged.
`
`Trademark Notice: Product or corporate names maybe trademarks or registered trademarks, and are used
`only for identification and explanation without intent to infringe.
`
`A CIP catalogue record for this book is available from the British Library
`
`Visit the Taylor & Francis Web site at
`http://www.taylorandfrancis.com
`and the CRC Press Web site at
`http://www.crcpress.com
`
`Page 3
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`13. The GENIC®; GENIC® SV and
`GENIC® LV Stent Systems
`
`Blue Medical Devices B. V., Hehnond, The Netherlands
`Henk JM Meens and Ronald AM Horvers
`
`Description The GENIC® is a balloon expandable coronary stent
`with a helical sinusoidal waveform geometry.
`
`Figure 13.1:
`Structure of the GENIC
`coronary stent.
`
`3
`
`• July—November 1999 development
`• December 1999 completing animal trials
`• December 1999 Development DYLYN®
`• January 2000 CE Mark
`• January 2000 first human implants
`• May 2000 Development SV/LV
`• December 2000 Development drug delivery
`• January 2001 CE Mark SV/LV
`• March 2001 CE Mark DYLYN®
`
`Figure 13.2:
`Expanded 18 mm
`GENIC coronary
`stent.
`
`Page 4
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Henk JM Meens and Ronald AM Horvers
`
`GENIC® coronary stent technical specifications
`
`Material composition:
`
`Radiopacity:
`
`Ferromagnetism:
`
`MRI:
`
`Metallic surface area
`expanded:
`unexpanded:
`
`316 L medical grade
`
`Moderate
`
`N on-ferromagnetic
`
`MRI safe
`
`14% at dia 3,0 mm
`28%
`
`Metallic cross-sectional area:
`
`0.14 mm2
`
`Stent design:
`
`Strut design:
`
`Strut dimensions:
`
`Strut thickness:
`
`Profiles
`expanded:
`crimped:
`
`Longitudinal flexibility
`Balloon/stent assy:
`Expanded stent:
`
`Shortening (expansion):
`
`Expansion range:
`
`Recoil:
`
`Radial force:
`
`Helical sinusoidal waves
`
`Rectangular with rounded edges
`
`0.11-0,12 mm wide
`
`0.10 mm
`
`2.5-4.0 mm
`< 1.0 mm (3.0 X 28)
`
`Excellent
`Excellent
`
`3-4% (3.0 X 18)
`
`2.3-4.5 mm
`
`3-5% (all sizes)
`
`Excellent
`
`Available diameters:
`
`2.5, 3.0, 3.5 and 4.0
`
`Available lengths
`Mounted:
`
`Available sizes:
`
`Recrossability:
`
`Other types:
`
`10, 14. 18. 22 and 28
`
`Full matrix
`
`Excellent
`
`Under development
`
`102
`
`Page 5
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The GENIC®, GENIC® SV and GENIC® LV Stent Systems
`
`GENIC® LV coronary stent technical specifications
`
`Material composition:
`
`Radiopacity:
`
`Ferromagnetism:
`
`MRI:
`
`Metallic surface area
`expanded:
`unexpanded:
`
`316 L medical grade
`
`Moderate
`
`Non-ferromagnetic
`
`MRI safe
`
`14% at dia. 4.0 mm
`30%
`
`Metallic cross-sectional area:
`
`0.17 mm2
`
`Stent design:
`
`Strut design:
`
`Strut dimensions:
`
`Strut thickness:
`
`Profiles
`expanded:
`crimped:
`
`Longitudinal flexibility
`Balloon/stent assy:
`Expanded stent:
`
`Shortening (expansion):
`
`Expansion range:
`
`Recoil:
`
`Radial force:
`
`Available diameters:
`
`Available lengths
`Mounted:
`
`Available sizes:
`
`Recrossability:
`
`Other types:
`
`Helical sinusoidal waves
`
`Rectangular with rounded edges
`
`0.10-0.13 mm wide
`
`0.1 1 mm
`
`4.0-5.0 mm
`s l.l mm (all sizes)
`
`Excellent
`Excellent
`
`4-5% (4.5 X 22)
`
`3.7-55 mm
`
`35-5.5% (all sizes)
`
`Excellent
`
`4.0, 4.5 and 5.0
`
`18, 22 and 28
`
`Full matrix
`
`Excellent
`
`Under development
`
`103
`
`Page 6
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Henk JM Meens and Ronald AM Horvers
`
`GENIC® SV coronary stent technical specifications
`
`Material composition:
`
`Radiopacity:
`
`Ferromagnetism:
`
`MRI:
`
`Metallic surface area
`expanded:
`unexpanded:
`
`316 L medical grade
`
`Moderate
`
`N on-ferromagn etic
`
`MRI safe
`
`14% at dia 4.0 mm
`26%
`
`Metallic cross-sectional area:
`
`0.1 1 mm2
`
`Helical sinusoidal waves
`
`Rectangular with rounded edges
`
`0.08 X 0.10 mm wide
`
`0.09 mm
`
`2.0-2.5 mm
`s 0.9 mm (all sizes)
`
`Excellent
`Excellent
`
`2-3% (2.5 X 14)
`
`1.8-2.8 mm
`
`2.5—4.5% (all sizes)
`
`Excellent
`
`2.0 and 2.5
`
`10, 14 and 18
`
`Full matrix
`
`Excellent
`
`Under development
`
`Stent design:
`
`Strut design:
`
`Strut dimensions:
`
`Strut thickness:
`
`Profiles
`expanded:
`crimped:
`
`Longitudinal flexibility
`Balloon/stent assy:
`Expanded stent:
`
`Shortening (expansion):
`
`Expansion range:
`
`Recoil:
`
`Radial force:
`
`Available diameters:
`
`Available lengths
`Mounted:
`
`Available sizes:
`
`Recrossability:
`
`Other types:
`
`104
`
`Page 7
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The GENIC®', GENIC® SV and GENIC® LV Stent Systems
`
`Tips and tricks for delivery
`
`• The GENIC®' coronary stent is premounted on a semi-compliant, high-
`pressure rapid exchange stent delivery catheter, with optimized
`pushability and distal flexibility, securing reliable performance.
`• The GENIC8' coronary stent is positioned between two platinum iridium
`balloon markers.
`• The GENIC® coronary stent delivery system is compatible with a 5 Fr
`guiding catheter.
`• After delivery the GENIC® coronary stent conforms to the natural
`anatomy of the coronary artery.
`
`Indications for use
`
`• The very flexible GENIC® coronary stent can be applied in a wide range
`of procedures, from straight stent procedures to procedures in complex
`tortuous paths and direct stenting.
`• The GENIC® coronary stent enables side branch access without decrease
`of robustness in the design.
`
`Why I like my stent
`
`• The unique geometric design of the GENIC® combines the well-
`appreciated flexibility of coil stents with the proven robustness of the
`tubular stents. The superb crimping technology enables direct stenting
`even through 5 Fr guiding catheters.
`• The GENIC®' coronary stent is designed to provide optimal flexibility
`mounted on the stent delivery system.
`• Due to this optimal combination, the GENIC® coronary stent and its
`stent delivery system has an extremely low profile and an excellent
`crossing performance.
`• The helical sinusoidal waveform geometry conforms to the natural
`dynamic tortuous coronary anatomy and prevents stretching of the
`vessel. This excellent flexibility allows placement in very dynamic
`coronary anatomy with less stress on the coronary vessel wall preventing
`restenosis at the extremities.
`
`105
`
`Page 8
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Henk JM Meens and Ronald AM Horvers
`
`Figure 13.3:
`Flexibility of the
`GENIC coronary
`stent delivery
`system.
`
`(«)
`
`(b)
`
`Figure 13.4: (a) Complete stenosis in tortuous proximal right coronary artery;
`(b) after GENIC stent implantation. This shows the excellent coirformability to the vessel
`wall of the expanded stent.
`
`106
`
`Page 9
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The GENIC®, GENIC® SV and GENIC® LV Stent Systems
`
`(a)
`
`(b)
`
`Figure 13.5: (a) Total occlusion of proximal right coronary artery; (b) after
`recanalization and GENIC stent implantation.
`
`Delivery device of GENIC®
`
`Mechanism of deployment:
`
`Balloon expandable
`
`Minimal internal guiding catheter:
`
`Maximal guidewire diameter:
`
`System:
`
`Design:
`
`Proximal shaft:
`
`Distal shaft:
`
`Number of markers:
`
`Type of markers:
`
`Position of markers:
`
`Position stent:
`
`Balloon material:
`
`Compliance:
`
`Nominal:
`
`0.056 inch
`
`0.014 inch
`
`Rapid exchange
`
`Hypo tube
`
`2.1 Fr
`
`2.6 Fr
`
`2
`
`Platinum iridium
`
`Proximal and distal balloon
`
`Between balloon markers
`
`Acrylon® (thermoplastic elastomer)
`
`Semi-compliant, high-pressure
`
`6 atm
`
`Rated burst pressure:
`
`16 atm (> 4.0 mm: 14 atm.)
`
`GENIC® is a registered trademark of Blue Medical Devices
`
`107
`
`Page 10
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`ji'}STI;N'I"' LIORUMM STEN'I' RANGE
`THi-
`’_____________.
`
`jOSTENT® Coronary Stcnt Graft
`
`
`
`[I Description
`~
`
`51
`
`I
`
`
`
`.1 uniquu MRI“ liri‘iiniiimgy which
`]UM]E1) has (ii-ri-i:_ipetl
`ri-iiri'w'i-IIL-i A III'\'- Na in i'::i‘nn.ii'_\ muting. 'l'iic
`IUS'I'IENT" L'ururmi'y Sll’lll Grail
`\'lIIH|FiHl‘.‘-i
`.I lh-xilflr
`SLL’HI
`\\ illi .1 Lin-r ul‘ i-xlmlitlaiili- |"1'l'i_: grail Illilh'l'iill
`:icsigiivcl For Mimi-55ml inaimgmu'nt ijii' .u-nlc mniim'
`siumlinnh‘.
`‘l‘lll‘ jUS'I‘I'N'I-J Cm'nnar}: Sli-nl Ural—1 l'HiIII‘JiI'IL'S .1“
`[hr liruprl‘iivs Ill-.1 graft Mini
`.1 i'nrnlmr} hll'lii. yvl
`il
`is .IS
`l'lL-xihh- .Is 1]1HH1_£'[i|'1\'L'l'lliill1-1| xii-ms. 'I'Iu- I( JS'I'I-iNl'"
`Coronary Sic-m l'ji'ail'l
`I145 iii-cu i‘llllhl'I'LIL'H'll L1} Llsillg ..
`uniqui- sandwii-h Lechniclue, “'IIL‘I'L‘IJ‘Y an uhraLhin 1.I}'ur
`ml“ i-xpatitialali' 1"I"F|-.
`is Iiim'rii in-Iu-u-rn hm sicnlh'.
`“'t‘ll't'ii at
`its I'IIEIH.
`
`I
`I
`
`|
`
`This iivsign li'i':]\"l{|l‘5 high radial slrunglli .Iml
`li'iugilluiiinal lirxilsiliti'
`.Imi Illt‘ ili-i'iu' um iiv Ci'illiiJL-{i
`:‘imxn IL!
`:1 in“ profit; u-i-i clusr to standard bar:- httffllfi
`{Ell-1' i'nl‘npntiiilr}.Thv unique. i'nnstructinli allows liil.‘
`]()S.|.|_N.[.-_ (IMF-mari'
`.‘ih'm Gmlkl
`Ill l'fli'l'lh't‘ly Mull HIT
`tiu- n-sm-l \mlli
`II am in: mil-IV implanti'nl .inti
`ix
`bunrlirini iJi'
`l"-'I.'I1 “IF-saving in i‘rii'omri' disk-minus.
`pcrl'c-Iunimis.
`.1I1elii'x':liis .1an bk'lldfifi graft
`li‘sions,
`
`I
`
`I
`
`I
`
`I
`
`l
`
`.‘
`I
`‘
`"
`.EFL'I‘Jir
`_.'..—-'9,}
`
`‘
`
`1 .
`
`.fl
`
`”guru 36.8.- NSTENT" ('nmmnj Hicni‘ (Enlifr.
`
`IPR2020-01343
`
`l3]
`
`Medtronic EX-1802
`
`Medtronic V. Teleflex
`
`Page 11
`
`Page 11
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`JOSTENT‘A0 Coronary Stem: Graft. ;te"chn_i_i;al specifications
`fl
`f"‘-.He_-I L11 mrHl'uruhun'
`416:5.
`'-|.1I‘.l|r-~'.-. J! .-| F'II-F
`-,
`...
`-
`.
`l‘.
`_‘
`.
`1
`-
`-
`.
`I):
`f'_';.,1l.‘.il'..;';\_iE\ {gm jv'li
`-' 1'._-{!'.'[-Llr_‘
`EJu-Jl'fip-
`Fi-rr'on*..1_y;-.191i5rn.
`Non-5r..-rmn'1.eylr1<+tii
`.'|:-_.'
`-_.|.-'_.
`
`l_l“IPJ. walla)
`
`IJH'ngn-u [H |(-‘-..¢ Ill
`.9.
`
`[til-'m :w nmrlul‘ }_
`J.
`
`' E:L:"_ . ,ir-.
`
`J‘IJ':
`
`‘N-JH 1|1|LLI".‘;".~‘-'
`
`i-‘EINI‘.
`
`'1 1' "l '.".1 .‘_‘
`
`”-‘H’U mth “H” mm]
`“anI -'I.
`
`{Sorry-my prohha— groan-mg {mafia}.
`
`elfjr’J-i ”.3? LI
`
`+3.
`
`Lr;r;5i1..-..*_:I:;1I {lr.')lb!‘.l1l.
`
`GOD!
`
`l“'l'f I.-|".1.::.1_!.-
`
`'-.1'I‘Il1:;‘.']lhj‘_ ”pun r‘rf'l'J-lf'l'wlf‘fl.
`
`'
`
`3‘91:-
`
`.11 3 IJ|H|11
`
`I_UI'|r'-I1T|‘_. d'-.u1i|.11_'l:r'
`
`|-
`
`'Iflh'a
`
`;.=I‘._|IT h r
`'_I.-.'i'.I
`.I' P: IN I1
`
`;‘_‘_l':
`
`U.
`
`l'.-.
`
`l‘.'
`
`.H-Ii
`
`'-.Ul'l'r'.'|'l1|:,-' avanlnbie dl.l.r~netr_‘.r~.:
`
`‘.'.'tr.--I
`
`:-
`
`:'.'I--
`
`r
`
`'L'-."-':"'_. “fl-:1
`
`2.3 U! 5.0 mm
`
`‘."E' -'..|‘.", ”If:
`
`_..'.'"
`___.'
`I
`' Tips and tricks for deh‘vcry “03'! EN 1 “' Coronary Stunt
`Graft)
`
`'
`'
`
`Inr' optima] rxpntuilnn u-u- inlhlinn Imwun-s Hf min. H H1 .l1m.
`[ls-:- I\-"LIH III L-murc- optimal drpluynn-nl.
`
`IPR2020-01343
`
`Medtronic EX-1802
`
`Medtronic V. Teleflex
`
`Page 12
`
`Page 12
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`17. The Lunar Coronary Stent
`System
`
`InFlow Dynamics AG, Munich, Germany
`Franz R Eberli and Stephan Windecker
`
`Definition
`
`History
`
`Starflex design is a homogeneous, multicellular stent
`structure with alternating stiff and flex segments for
`excellent longitudinal flexibility; the Niobium alloy stent
`is coated with iridium oxide, which facilitates the
`growth of endothelial cells and reduces the inflammatory
`response to stent mediated vascular injury.
`
`• September 2000, CE mark received
`• December 2000, clinical evaluation at Swiss
`Cardiovascular Center, Bern, Switzerland
`• March 2001, multicenter registry study ‘Moonlight’
`with six European centres
`• March 2001, first live case with lunar coronary stent
`system from Inselspital, Bern, Switzerland, to
`Percutaneous Endovascular Therapeutics Congress,
`Santa Fe, Argentina
`
`Figure 17.1: Expanded unmounted Lunar® coronary stent. Insert shows the
`magnified surface.
`
`Page 13
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Franz R Eberli and Stephan Windecker
`
`Figure 17.2: Balloon mounted Lunar® coronary stent.
`
`(b)
`
`Figure 17.3: (a) Electron microscopy of Lunar® stent, (h) Electron microscopy of
`Lunar stent surface showing the particularly rough suface structure of the iridium
`oxide coated stent. It is assumed that the iridium oxide coated, rough suf ace facilitates
`adhesion and growth of endothelial cells.
`
`Figure 17.4: Schematic cross-sectional drawing highlighting the special construction
`of the Lunar stent. The Niobium core of the stent is covered with the iridium oxide. The
`Niobium alloy is a heavy-metal-free material, with the same mechanical features as
`steel. This corrosion-free clinically proven material has self-healing features. The iridium
`oxide decreases the formation of free oxygen radicals, and thus decreases the
`inflammatory stimulus cfter stent implantation.
`
`142
`
`Page 14
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Lunar Coronary Stent System
`
`Lunar stent technical specifications
`
`Matenal composition:
`
`Niobium alloy stent body iridium oxide
`coated
`
`Degree of radiopacity (grade):
`
`Superior
`
`Ferromagnetism:
`
`MRI:
`
`Metallic surface area:
`
`Stent design:
`
`Strut design:
`
`Strut dimensions:
`
`Strut angles:
`
`Strut thickness:
`
`Crossing profile(s) on the balloons:
`
`Non-ferromagnetic
`
`MRI-proof
`
`Dependent on expanded diameter
`(13-19%)
`
`Homogeneous, multicellular stent
`structure, 'Starflex' - design
`
`Oval strut cross-section
`
`90 X 85 pm
`
`Dependent on diameter
`
`90 pm
`
`2.5 mm balloon diameter: 0.0382 inch =
`0.96 mm
`4.0 balloon diameter; 0.0471 inch =
`1.20 mm
`
`Longitudinal flexibility:
`
`Percentage shortening (on delivery):
`
`Percentage shortening on expansion:
`
`Expansion range:
`
`Degree of recoil (shape memory):
`
`Radial force:
`
`Good
`
`0%
`
`<3%
`
`2.5-4.5 mm
`
`<3%
`
`High
`
`Currently available diameters:
`
`2.5-4.0 mm
`
`Currently available lengths
`Mounted/implanted
`Unmounted:
`
`Currently available sizes:
`
`8 mm* 12 mm, 16 mm, 20 mm,
`24 mm* 32 mm
`
`Each length for 2.5/3.0/3.5/4.0 mm
`balloon diameter
`
`Recrossability of implanted stent:
`
`Excellent
`
`Other non-coronary types available
`
`Peripheral stents
`Antares Endovascular OTW
`Antares Renal RX
`
`* Planned
`
`143
`
`Page 15
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Franz R Eberli and Stephan Windecker
`
`Figure 17.5: A stenosis in the mid-right coronary artery (a) was treated with the
`Lunar® coronary stent (b). Fluoroscopy reveals the high radiopacity of the Lunar®
`stent (c). At 6 months, follow-up angiography shows an excellent late result with
`minimal restenosis (d).
`
`Figure 17.6:1VUS image of a
`fully deployed Lunar® stent.
`
`144
`
`Page 16
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Lunar Coronary Stent System
`
`Indications for use
`In patients eligible for balloon angioplasty with symptomatic ischemic
`•
`heart disease characterized by discrete de novo and restenosed coronary
`artery lesions with reference vessel diameter from 2.5 mm to 4.5 mm.
`In elective implantation and in treatment of acute or threatened closure
`associated with a coronary intervention, including saphenous vein grafts.
`
`•
`
`Why I like this stent
`Conceptual considerations: The Lunar® Coronary Stent System consists of a
`Niobium alloy stent body and a layer of homogeneous iridium oxide. The
`Niobium alloy is a heavy-metal-free material, with the same mechanical
`features as steel, but with excellent visibility. This corrosion-free clinically
`proven material has self-healing features.
`The Lunar® coronary stent system special coating consists of a layer of
`ductile gold and a top layer of homogeneous iridium oxide. The gold
`coating assures fissure-free deployment and is also responsible for the
`excellent visibility of the stent. The iridium oxide coating is believed to
`reduce in-stent restenosis by decreasing the inflammatory response to the
`stent via its antioxidant action. A metallic stent induces a leucocyte
`reponse as soon as it is deployed. The leucoytes release hydrogen peroxide
`(H2O2), which stimulates the proliferation of vascular smooth muscle cells
`both directly via the activation of NF-kB, or indirectly via tihe formation of
`peroxynitrite. Iridium oxide has high catalytic properties, and cleaves H2O2
`into water and oxygen. Therefore, the release and activation of free
`radicals, which provoke smooth muscle cell growth, is reduced.
`Experimentally, iridium oxide reduced by 50% free radical formation by
`stimulated leucocytes adherent to stent struts. Iridium oxide layers form a
`rough surface. Experimentally, adhesion of endothelial cells to the rough
`stent surface was markedly increased as compared to a smooth stent
`surface. In summary, the iridium oxide coating may promote endothelial
`coverage of the implanted stent while reducing free oxygen radical
`formation and the inflammatory response, thus reducing smooth muscle
`cell proliferation and in-stent restenosis. This stent property is maintained
`over time. The iridium oxide coating is not degraded. Therefore, the Lunar
`stent is not a drug eluting stent, whose effects are time-dependent.
`
`145
`
`Page 17
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Franz R Eberli and Stephan Windecker
`
`Tips and tricks for delivery
`The low profile of the Lunar stent allows easy delivery through 5 Fr
`guiding catheter systems. The crimping is adequate. The stent delivery
`system is suitable for direct stenting, but extremely tortuous vessels and
`calcification should be avoided.
`
`Ongoing studies
`• Moonlight study: European prospective, multicentre registry of 1 20
`consecutive patients with single or multivessel disease. Follow-up 1 and
`6 months. Started March 2001.
`• Clinical evaluation of the Lunar coronary stent system at the Swiss
`Cardiovascular Center, Bern, Switzerland
`• Clinical evaluation of the Lunar coronary stent system in Argentina and
`Brazil, with 40 patients.
`
`146
`
`Page 18
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`32. The Spiral Force Stent
`
`Bolton Medical Inc. Fair Lawn, NJ, USA
`Norman T Kanesaka and Tomas Berrazueta
`
`Definition
`
`The Spiral Force coronary stent is a tubular stent, which
`is cut from 316 L stainless steel and electro-polished. It
`features a unique spiral strut design in which all of the
`struts are connected with inverted C-joints. This spiral
`design provides unsurpassed flexibility, while the
`connection of all struts ensures uniform expansion and a
`high radial force. The stent offers outstanding radial
`force and minimum recoil, because the scaffolding
`design connects all struts together for uniform
`distribution of support.
`
`Introduced in 1999 and distributed worldwide since
`then. The Spiral Force’s unique spiral design provides
`excellent flexibility.
`
`Figure 32.1:
`Electron
`micrograph oj
`Spiral Force
`Stent.
`
`Page 19
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Norman T Kanesaka and Tomas Berrazueta
`
`Figure 32.2: Spiral Force Stent, pre- and post-LAD implantation.
`
`Figure 32.3: Spiral Force Stent, pre- and post-RCA implantation.
`
`Figure 32.4: Spiral Force Stent, pre- and post-LAD implantation.
`
`268
`
`Page 20
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Spiral Force Stent
`
`Spiral Force stent technical specifications
`
`Material composition:
`
`316 L stainless steel
`
`Degree of radiopacity (grade):
`
`Moderate
`
`Ferromagnetism:
`
`MRI:
`
`Stent design:
`
`Strut design:
`
`Strut dimensions: '
`
`Strut angles:
`
`Strut thickness:
`
`Wire thickness:
`
`Mesh angle:
`
`Mesh braid angle:
`
`Non-Ferromagnetic
`
`MRI Safe
`
`Spiral cut with C-joints
`
`Straight struts
`
`0.005 inch X 0.026 inch to 0.005 inch X
`0,035 inch
`
`40“M5o 4 mm internal diameter
`
`0.003 inch
`
`Not applicable
`
`Not applicable
`
`Not applicable
`
`Profile(s): non-expanded (uncrimped):
`expanded:
`on the balloons:
`
`0.067 inch
`2.7 to 4.2 mm
`0.039 inch to 0.042 inch
`
`Longitudinal flexibility:
`
`Excellent
`
`Percentage shortening on expansion;
`
`3.8—8.2% depending an expansion
`
`Expansion range:
`
`2.5 mm to 4.25 mm
`
`Degree of recoil (shape memory):
`
`1.2%
`
`Radial force:
`
`Very high
`
`Currently available diameters:
`
`2.5, 3.0, 3.5, 4.0 mm
`
`Currently available lengths
`mounted/unmounted:
`
`9, 13, 17, 21 and 27
`
`Other non-coronary types available:
`
`Femoral, iliac, renal in late 2001
`
`Delivery system
`
`The rapid exchange Runner is the latest generation stent delivery balloon
`catheter. The Zylite balloon material (semi-compliant) gives: controlled
`compliance, increased flexibility, optimal refolding and high pressure
`seating.
`The Runner balloon is also designed to be used for standard PTCA
`procedures, such as routine pre-dilatation angioplasty and post-stent
`deployment. It is available in all lengths and diameters.
`
`269
`
`Page 21
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Norman T Kanesaka and Tomas Berrazueta
`
`Tips and tricks for delivery
`This is a really simple stent to use clue to the adequate radiopacity and
`flexibility. Due to the low compliance of the balloon and the easy stent
`expansion at mid-pressures, it is recommended to slightly oversize the
`stent. It is unusual to observe distal dissections. All sizes of tire Spiral
`Force stent can be easily delivered through all commercially available 6 Fr
`guiding catheters and through a Medtronic Zuma S Fr guiding catheter.
`
`Figure 32.5: Spiral Force premounted on the Runner delivery system.
`
`Figure 32.6: Spiral Force stent.
`
`270
`
`Page 22
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Spiral Force Stent
`
`Indications for use
`The Spiral Force (SF)™ balloon-expandable stent is indicated for use in de
`novo native coronary artery lesions with a reference vessel diameter in the
`range of 2.5 —4 mm and a length up to 25 mm. In this population, stenting
`produces a larger luminal diameter, maintains arterial patency, and reduces
`the incidence of restenosis at six months as compared with balloon
`angioplasty. One year and longer follow-up is not well characterized.
`
`Why I like my stent
`There are many specifications for stents, but three major factors —
`flexibility, radial force and recoil — play the major roles in short and long
`term performance of the stent. Flexibility can be obtained either by design
`configuration or skipping connections. Higher radial force can be achieved
`from using a thicker material or connecting all struts. Reduced recoil rate
`is a design and material issue. The Spiral Force stent successfully comprises
`all three factors.
`The Spiral Force achieves all three goals with superior engineering
`without compromising other factors nor resorting to the easier solutions.
`
`Studies in which stent is involved
`1) JAPAN:
`Japanese Spiral Force Study - 100 Patients (Finished)
`2) SPAIN + PORTUGAL:
`RESET (Spiral Force Spanish Registry) — 428 Patients (Finished)
`3) BELGIUM:
`SPIFO (Spiral Force Patency, Belgium Study) — 75 Patients (Running)
`4) FRANCE:
`Spiral Force French Registry — 125 Patients (Running)
`
`271
`
`Page 23
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`33. The Tsunami Coronary Stent
`System
`
`Terumo Corporation, Japan
`Masakiyo Nobuyoshi
`
`Description
`
`• Balloon expandable
`• Stainless steel slotted tube stent
`• Double-linked diamond cell structure
`
`Important features of Tsunami
`• Superb deliverability
`Hydrophilic M coat™ is applied onto the tip and distal shaft of the
`delivery balloon catheter, decreasing friction when moistened. In
`addition to the M coat™, the benefits of the ultra-low profile
`(0.038 inch for 3.0 mm system), the unique double-link connection, the
`smooth stent surface, and the Tri-fold balloon combine to ensure superb
`stent delivery, trackability and crossability.
`• Exceptional conformability
`Terumo’s double-link structure — diamond-shaped cells joined by two
`connectors — results in unequalled stent flexibility. This pliable stent
`gives exceptional conformability to natural tortuosity of coronary
`vessels once deployed.
`• Powerful and stable radial force
`Radial strength and vessel coverage on bends are assured by the stainless
`steel laser-cut tube design and the double-link cell pattern. When
`placed in the lesion, the stent firmly retains its shape and position.
`• Minimum injury and maximum security
`Tsunami’s minimal balloon overhang (< 1 mm) lessens injury during
`dilatation. In addition, tire stent edge design reduces flaring risk
`providing more secure procedure.
`
`Page 24
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Masakiyo Nobuyoshi
`
`Tsunami technical specifications
`
`Material composition:
`
`Degree of radiopacity:
`
`Ferromagnetism:
`
`MRI:
`
`Metallic surtace area expanded:
`
`316 L stainless steel
`
`Moderate
`
`Moderate
`
`Safe
`
`< 18%
`
`Stent design:
`
`Strut design:
`
`Strut thickness:
`
`Ncn-expanded profile:
`
`Longitudinal flexibility:
`
`Percentage shortening:
`
`Degree of recoil:
`
`Current available sizes:
`
`Several radial diamonds joined by double
`connector
`
`Square
`
`0.08 mm
`
`0.95 mm (0.038 inch) for the 3.0 mm
`stent system
`
`Excellent
`
`<5%
`
`<5%
`
`2.5/15, 2.5/20, 2.5/30
`3.0/10, 3.0/15, 3.0/20. 3.0/30
`3.5/10, 3.5/15, 3.5/20. 3.5/30
`4.0/10. 4.0/15. 4.0/20
`
`Other non-coronary types available:
`
`None
`
`Tsunami stent delivery system
`
`Mechanism of deployment;
`
`Balloon expandable
`
`Minimal internal diameter of guiding
`catheter
`
`Pre-mounted on delivery catheter
`
`Protective sheath/covec
`
`0.056 inch, 5 Fr
`
`Yes
`
`No
`
`Position of radiopaque markei's:
`
`Distal and proximal to stent
`
`Recommended deployment pressure:
`
`Nominal at 10 atm (9 atm for 4.0 mm)
`
`Further balloon expansion recommended
`
`Discretionary
`
`Supply in bare
`
`Recrossability of deployed stent
`
`No
`
`Good
`
`Sizing diameter
`
`Equal to artery or over-sizing up to 10%
`
`274
`
`Page 25
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Tsunami Coronary Stent System
`
`Figure 33.1: Tsunami — conformability.
`
`Figure 33.2: Tsunami product range (10, 15, 20 and 30 mm lengths).
`
`275
`
`Page 26
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Masakiyo Nobuyoshi
`
`Figure 33.4: Expanded Tsunami stent system.
`
`276
`
`Page 27
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Tsunami Coronary Stent System
`
`Figure 33.5:
`Expanded Tsunami
`stent.
`
`Figure 33.6: Technical drawing of Tsunami.
`
`277
`
`Page 28
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Masakiyo Nobuyoshi
`
`Indications for use
`• Useful in distal and tortuous vessel
`• Long lesions
`• Acute closure or bail out situations
`• Smaller vessels
`• Acute myocardial infarction
`• De-novo lesions
`• Lesions in bends
`• Vein graft stenosis
`• Sub-optimal PTC A result
`• Moderate calcified lesions
`
`Why I like my stent
`• Superior deliverability assured by very low profile (one of the lowest),
`M coat (Terumo’s hydrophilic polymer on tip and shaft), and flexible
`system (unique double-link connection).
`• Good conformability and high radial force for long-term outcome
`provided by double-linked diamond cells tubular structure.
`• Minimum vessel injury realized by minimal balloon overhang.
`
`Ongoing planned trials
`• Japan trial, Dr Masakiyo Nobuyoshi, Kokura Memorial Hospital, Japan
`• TESTER, Professor Serruys, Thoraxcenter, Rotterdam, The
`Netherlands
`
`Review of the current published literature
`• Nobuyoshi M, Yokoi H, Mitsudo K, Kadota K, Saito S, Hosokawa J.
`Early and late outcomes of Coronary Stent System (TRE-963). J Clin
`Exp Med 1998;75:209-221.
`• Yokoi H, NakagawaY, Tamura T, Hamasaki N, Kimura T, Nosaka H,
`Nobuyoshi M. Preliminary experiences with tire Terumo coronary stent
`[abstract]. J Am Coll Cardiol 1998;31 (suppl):41 3A.
`
`278
`
`Page 29
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`34. The Zebra Stent
`
`Bolton Medical Inc, Fair Lawn, NJ, USA
`Norman T Kanesaka and Tomas Berrazueta
`
`Definition
`
`The Zebra coronary stent is a tubular stent, which is
`laser cut from 316 L stainless steel and electro-polished.
`It has bigger cells on both ends to give a ‘variable
`metal coverage’. The central part features a spiral strut
`design in which all of the stents are connected with
`inverted C joints.
`
`The Zebra was developed in mid-2000 to incorporate all
`the superior features of Bolton Medical’s Spiral Force
`stent — flexibility, high radial force and minimum recoil
`— with reduced metal coverage on the stent ends for
`better transitions to the non-stented areas.
`
`Figure 34.1: Expanded Zebra stent.
`
`Figure 34.2: Scanning
`electron micrograph of the Zebra
`stent.
`
`Page 30
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`Norman T Kanesaka and TomAs Berrazueta
`
`Zebra stent technical specifications
`
`Material composition:
`
`316 L stainless steel
`
`Degree of radiopacity (grade):
`
`Moderate
`
`Ferromagnetism:
`
`MRI;
`
`Non-femomagnetic
`
`MRI safe
`
`Metallic surface area expanded:
`
`Approximately I 3% at 3.5 mm
`
`Stent design:
`
`Strut design:
`
`Strut dimensions:
`
`Strut angles:
`
`Strut thickness:
`
`Wire thickness:
`
`Mesh angle:
`
`Mesh braid angle:
`
`Spiral cut with C-joints
`
`Straight struts
`
`0.005 inch x 0.0'26 inch to
`0.007 inch X 0.080 inch
`
`40° to 55° @ 4 mm internal diameter
`
`0.003 inch
`
`Not Applicable
`
`Not applicable
`
`Not applicable
`
`Profile(s): non-expanded (uncrimped):
`expanded:
`on the balloons:
`
`0.067 inch
`2.7 mm to 4.2 mm
`0.039 inch to 0.042 inch
`
`Longitudinal flexibility:
`
`Excellent
`
`Percentage shortening on expansion:
`
`2.5-10.8% depending on expansion
`
`Expansion range:
`
`2.5 mm to 4.25 mm
`
`Degree of recoil (shape memory):
`
`1.2%
`
`Radial force:
`
`Very high
`
`Currently available diameters:
`
`2.5, 3.0. 3.5, 4.0 mm
`
`Currently available lengths
`mounted/implanted:
`unmounted:
`
`See tables
`14 mm, 19 mm
`
`280
`
`Page 31
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

`

`The Zebra Stent
`
`Device for delivery
`The rapid exchange Runner is the latest generation stent delivery balloon
`catheter. The Zylite balloon material (semi-compliant) gives: controlled
`compliance, increased flexibility, optimal refolding and high pressure
`seating.
`The Runner balloon is also designed to be used for standard PTC A
`procedures, such as routine pre-dilatation angioplasty and post-stent
`deployment. It is available in all lengths and diameters.
`
`Indications for use
`See Spiral Force chapter.
`
`Why I like my stent
`The Zebra inherits all of the superior, fundamental design patterns of
`Bolton Medical’s Spiral Force in the center of the stent, but the end cells
`are enlarged for reduced metal coverage. This is a very unique design.
`
`Studies in which stent is involved
`1) ZEBRA BELGIUM STUDY
`7 centres
`ISO patients
`Registry
`Will start on June 2001
`
`2) ZEBRA SPAIN STUDY
`S centres
`200 patients
`Registry
`Will start on June 2001
`
`281
`
`Page 32
`
`IPR2020-01343
`
`Medtronic Ex-1802
`Medtronic v. Teleflex
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket